139 related articles for article (PubMed ID: 31117973)
1. Correlations between periodontal disease, mandibular inferior cortex index and the osteoporotic fracture probability assessed by means of the fracture risk assessment body mass index tool.
Kalinowski P; Różyło-Kalinowska I; Piskórz M; Bojakowska-Komsta U
BMC Med Imaging; 2019 May; 19(1):41. PubMed ID: 31117973
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX.
Horner K; Allen P; Graham J; Jacobs R; Boonen S; Pavitt S; Nackaerts O; Marjanovic E; Adams JE; Karayianni K; Lindh C; van der Stelt P; Devlin H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):243-9. PubMed ID: 20659701
[TBL] [Abstract][Full Text] [Related]
3. Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
Holloway KL; Mohebbi M; Betson AG; Hans D; Hyde NK; Brennan-Olsen SL; Kotowicz MA; Pasco JA
Osteoporos Int; 2018 Jan; 29(1):101-108. PubMed ID: 28940052
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hip fracture in Brazil and the development of a FRAX model.
Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
[TBL] [Abstract][Full Text] [Related]
5. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
Phuan-Udom R; Lektrakul N; Katchamart W
Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and radiographic indices as predictors of osteoporotic fractures: a 10-year longitudinal study.
Jonasson GB; Sundh V; Hakeberg M; Ahlqwist M; Lissner L; Hange D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):487-494. PubMed ID: 29273194
[TBL] [Abstract][Full Text] [Related]
7. FRAX-based Estimates of 10-year Probability of Hip and Major Osteoporotic Fracture Among Adults Aged 40 and Over: United States, 2013 and 2014.
Looker AC; Sarafrazi Isfahani N; Fan B; Shepherd JA
Natl Health Stat Report; 2017 Mar; (103):1-16. PubMed ID: 28459415
[TBL] [Abstract][Full Text] [Related]
8. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
10. Panoramic radiomorphometry and vertebral fractures in Spanish postmenopausal women.
Martínez-Maestre MÁ; Corcuera Flores JR; Machuca G; González-Cejudo C; Torrejón R; Castelo-Branco C
Maturitas; 2013 Dec; 76(4):364-9. PubMed ID: 24090925
[TBL] [Abstract][Full Text] [Related]
11. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.
McCloskey EV; Johansson H; Oden A; Austin M; Siris E; Wang A; Lewiecki EM; Lorenc R; Libanati C; Kanis JA
J Bone Miner Res; 2012 Jul; 27(7):1480-6. PubMed ID: 22431426
[TBL] [Abstract][Full Text] [Related]
12. A pilot screening study for low bone mass in Singaporean women using years since menopause and BMI.
Ang SB; Xia JY; Cheng SJ; Chua MT; Goh L; Dhaliwal SS
Climacteric; 2022 Apr; 25(2):163-169. PubMed ID: 33928868
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
[TBL] [Abstract][Full Text] [Related]
14. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
Badurski J; Jeziernicka E; Dobreńko A; Nowak N; Daniluk S; Rybaczuk M; Wiśniowiecka M
Endokrynol Pol; 2011; 62(4):290-8. PubMed ID: 21879467
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
[TBL] [Abstract][Full Text] [Related]
17. Agreement of Mexican FRAX with and without the value of bone mineral density in assessing the risk of fracture in daily clinical practice.
Horta-Baas G; Pérez Bolde-Hernández A; Pérez-Pérez A; Vergara-Sánchez I; Romero-Figueroa MDS
Med Clin (Barc); 2017 May; 148(9):387-393. PubMed ID: 28118961
[TBL] [Abstract][Full Text] [Related]
18. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
[TBL] [Abstract][Full Text] [Related]
19. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
20. Development and application of FRAX in the management of osteoporosis in Ireland.
McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
